Development of COVID-19 vaccines utilizing gene therapy technology - PubMed (nih.gov)It's not gene therapy, gene-ius. And you're not forced to take it.
COVID-19 Vaccine Candidates Demonstrate Gene Therapy is a Viable Strategy | ASGCT - American Society of Gene & Cell Therapy
Two COVID-19 vaccine trials, both of which use messenger RNA (or mRNA) technology to teach the body to fight the virus, have reported efficacy over 90 percent.
These findings, announced by Moderna on Nov. 16 and by Pfizer and its partner BioNTech on Nov. 9 (with an update on Nov. 18), demonstrate that gene therapy is a viable strategy for developing vaccines to combat COVID-19. Both vaccine candidates use mRNA to program a person's cells to produce many copies of a fragment of the virus. The fragment then stimulates the immune system to attack if the real virus tries to invade the body.